Stefan Thierfelder
7Patents
6h-index
4Co-inventors
45Inventor score
Filing activity: May 7, 1997 → Oct 21, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6551592B2 | Bi-and trispecific antibodies for the induction of anti-tumor immunity | Chemistry; Metallurgy | 157 | Expired |
| US5985276A | Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies | Chemistry; Metallurgy | 32 | Expired |
| US6210668A | Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies | Chemistry; Metallurgy | 29 | Expired |
| US6294167A | Pharmaceutical compositions for immunotherapy containing antibodies which specifically recognize the MHCII antigen of a patient to be treated | Human Necessities | 19 | Expired |
| US5830473A | Antibodies against T cells as therapeutics | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6290955A | Antibodies against T cells as therapeutics | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6007807A | Induction of tumour immunity by injection of hybrid cells | Human Necessities | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.